Trial NCT02120417

View at ClinicalTrials.gov 
Org. Study IDs: INCB 18424-268

Last trial update was posted on 2018-02-13

MeSH Interventions

Capecitabine

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

The study was terminated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID